Experiment Overview
| Repository ID: | FR-FCM-ZYQQ | Experiment name: | MC38 combination therapy | MIFlowCyt score: | 19.50% |
| Primary researcher: | Spencer Wei | PI/manager: | Spencer Wei | Uploaded by: | Spencer Wei |
| Experiment dates: | 2016-10-01 - 2018-10-01 | Dataset uploaded: | Sep 2018 | Last updated: | Oct 2019 |
| Keywords: | None | Manuscripts: | |||
| Organizations: | None | ||||
| Purpose: | To characterize the cellular mechanisms of anti-CTLA-4, anti-PD-1, and combination therapy using a preclinical tumor model. | ||||
| Conclusion: | None | ||||
| Comments: | None | ||||
| Funding: | Not disclosed | ||||
| Quality control: | Data are acquired in three biological replicate cohorts (see attached annotation). Each cohort was barcoded. Data is bead normalized, debar coded, and gated for T cells. | ||||
